No abstract available
Publication types
-
Case Reports
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carrier Proteins / genetics*
-
Cell Cycle Proteins*
-
Chromosome Deletion*
-
Chromosomes, Human, Pair 9 / genetics
-
Chromosomes, Human, Pair 9 / ultrastructure*
-
Cyclin-Dependent Kinase Inhibitor p15
-
Cyclin-Dependent Kinase Inhibitor p16
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Drug Resistance, Neoplasm
-
Etoposide / administration & dosage
-
Fatal Outcome
-
Gene Deletion*
-
Humans
-
Immunologic Factors / therapeutic use*
-
Interferon-alpha / therapeutic use*
-
Male
-
Neoplasm Proteins / deficiency
-
Neoplasm Proteins / genetics*
-
Neoplastic Stem Cells / pathology*
-
Polymerase Chain Reaction
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Prednisone / administration & dosage
-
RNA, Messenger / genetics
-
RNA, Neoplasm / genetics
-
Salvage Therapy
-
Tumor Suppressor Proteins*
-
Vincristine / administration & dosage
Substances
-
CDKN2B protein, human
-
Carrier Proteins
-
Cell Cycle Proteins
-
Cyclin-Dependent Kinase Inhibitor p15
-
Cyclin-Dependent Kinase Inhibitor p16
-
Immunologic Factors
-
Interferon-alpha
-
Neoplasm Proteins
-
RNA, Messenger
-
RNA, Neoplasm
-
Tumor Suppressor Proteins
-
Cytarabine
-
Vincristine
-
Etoposide
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone
-
Daunorubicin